secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lipocine Inc. (LPCN)
CIK:        0001535955
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001493152-26-008852
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipocine files $50M ATM equity facility with A.G.P./Alliance Global Partners
----------------------------------------------------------------------------

- Filed prospectus supplement on Feb 26, 2026 for sale of up to $50M common stock via ATM.
- Sales agreement originally dated April 26, 2024 with A.G.P./Alliance Global Partners.
- Legal opinion on share validity from Dorsey & Whitney LLP included as Exhibit 5.1.
- No specific use of proceeds disclosed in the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1535955/000149315226008852/0001493152-26-008852-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1535955/000149315226008852/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008852

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer